Jad Sfeir
@jadsfeir.bsky.social
Endocrinologist & Gerontologist #MayoClinic #KogodCenter, with a focus on #osteoporosis and bone diseases, AUB alumnus 🇱🇧🏳️🌈
Our state-of-the-art review on osteoporosis management 👇🏼
Osteoporosis is a chronic disease mainly prevalent in older people.
What's the latest evidence on risk management and therapeutics for its treatment?
www.bmj.com/content/390/...
What's the latest evidence on risk management and therapeutics for its treatment?
www.bmj.com/content/390/...
August 22, 2025 at 11:59 PM
Our state-of-the-art review on osteoporosis management 👇🏼
Reposted by Jad Sfeir
We celebrate our members @asbmr.bsky.social! Today, we're highlighting @jadsfeir.bsky.social from @mayoclinic.org who serves as the Bone Core Group Chair. Jad studies skeletal senescence and aging in Type2 Diabetes patients. Check out his most recent publication on this topic! #ASBMRmemberspotlight
June 17, 2025 at 2:29 PM
We celebrate our members @asbmr.bsky.social! Today, we're highlighting @jadsfeir.bsky.social from @mayoclinic.org who serves as the Bone Core Group Chair. Jad studies skeletal senescence and aging in Type2 Diabetes patients. Check out his most recent publication on this topic! #ASBMRmemberspotlight
Reposted by Jad Sfeir
Osteoporosis is a chronic disease mainly prevalent in older people.
What's the latest evidence on risk management and therapeutics for its treatment?
www.bmj.com/content/390/...
What's the latest evidence on risk management and therapeutics for its treatment?
www.bmj.com/content/390/...
July 30, 2025 at 1:22 PM
Osteoporosis is a chronic disease mainly prevalent in older people.
What's the latest evidence on risk management and therapeutics for its treatment?
www.bmj.com/content/390/...
What's the latest evidence on risk management and therapeutics for its treatment?
www.bmj.com/content/390/...